MannKind Corporation (MNKD): A Bull Case Theory

We came across a bullish thesis on MannKind Corporation on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on MNKD. MannKind Corporation’s share was trading at $3.5000 as of February 25th. MNKD’s trailing and forward P/E were 49.91 and 34.36, respectively according to Yahoo Finance. MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. MNKD is emerging as a compelling growth story, driven by its lead ...